文献速递血液净化与透析

起始透析患者死亡风险预测:系统综述与Meta分析

Prediction of Risk of Death for Patients Starting Dialysis: A Systematic Review and Meta-Analysis.
PubMed 文献 · Clin J Am Soc Nephrol · 2019-07-30

该研究系统检索了至2018年12月的文献,纳入36项研究、32个预后指数,预测窗口3个月至10年。结论认为已有多个验证良好的指数可用于预测透析起始时的生存率。

要点

  • 起始透析患者死亡预测指数总体AUC为0.71,区分度良好。
  • Obi、Ivory和Charlson合并症指数AUC最高(0.74),其中CCI最常用。
  • 32个指数中仅10个经过外部验证,16个内部验证。

核心结论

  • 多个验证良好的预后指数可用于预测起始透析患者的生存率,区分度良好。

研究设计与样本

  • 遵循PRISMA指南的系统综述与Meta分析,检索Ovid MEDLINE、Embase、CENTRAL、Cochrane系统综述数据库和Scopus,截至2018年12月31日。
  • 最终纳入36项研究,描述32个预后指数,队列样本量46至52,796例,预测窗口3个月至10年。

主要发现

  • 按指数分层,Obi、Ivory和Charlson合并症指数(CCI)的AUC最高为0.74,CCI最常用(10项研究)。
  • 其他常用指数:Kahn-Wright指数(8项研究,AUC 0.68)、Hemmelgarn改良CCI(6项研究,AUC 0.66)、REIN指数(5项研究,AUC 0.69)。
  • 32个指数中,10个经过外部验证,16个内部验证,9个为预先存在的已验证指数。

临床怎么用

  • 临床可借助验证良好的预后指数(如CCI、Obi、Ivory)与起始透析患者沟通死亡风险,辅助共同决策。

局限性

  • 纳入研究间存在高度异质性(I²=99.12)。
  • 排除了针对 prevalent 透析患者的大队列研究。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND OBJECTIVES: Dialysis is a preference-sensitive decision where prognosis may play an important role. Although patients desire risk prediction, nephrologists are wary of sharing this information. We reviewed the performance of prognostic indices for patients starting dialysis to facilitate bedside translation. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: Systematic review and meta-analysis following the PRISMA guidelines. We searched Ovid MEDLINE, Ovid Embase, Ovid Central Register of Controlled Trials, Ovid Cochrane Database of Systematic Reviews, and Scopus for eligible studies of patients starting dialysis published from inception to December 31, 2018. SELECTION CRITERIA: Articles describing validated prognostic indices predicting mortality at the start of dialysis. We excluded studies limited to prevalent dialysis patients, AKI and studies excluding mortality in the first 1-3 months. Two reviewers independently screened abstracts, performed full text assessment of inclusion criteria and extracted: study design, setting, population demographics, index performance and risk of bias. Pre-planned random effects meta-analysis was performed stratified by index and predictive window to reduce heterogeneity. RESULTS: Of 12,132 articles screened and 214 reviewed in full text, 36 studies were included describing 32 prognostic indices. Predictive windows ranged from 3 months to 10 years, cohort sizes from 46 to 52,796. Meta-analysis showed discrimination area under the curve (AUC) of 0.71 (95% confidence interval, 0.69 to 073) with high heterogeneity (I2=99.12). Meta-analysis by index showed highest AUC for The Obi, Ivory, and Charlson comorbidity index (CCI)=0.74, also CCI was the most commonly used (ten studies). Other commonly used indices were Kahn-Wright index (eight studies, AUC 0.68), Hemmelgarn modification of the CCI (six studies, AUC 0.66) and REIN index (five studies, AUC 0.69). Of the indices, ten have been validated externally, 16 internally and nine were pre-existing validated indices. Limitations include heterogeneity and exclusion of large cohort studies in prevalent patients. CONCLUSIONS: Several well validated indices with good discrimination are available for predicting survival at dialysis start.

来源:Clin J Am Soc Nephrol,查看原文。版权归原作者所有。

引用

  1. Anderson RT, Cleek H, Pajouhi AS, et al. Prediction of Risk of Death for Patients Starting Dialysis: A Systematic Review and Meta-Analysis. Clin J Am Soc Nephrol. 2019. PMID: 31362990. doi:10.2215/CJN.00050119

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。